← Back to Home

Brief Squeezing Opens Genetic Switches: Conversion of Mouse Skin Cells into Neurons Rises to 40%

The barrier to changing a cell’s identity may lie in tightly packed DNA. A UCLA study combined mechanical squeezing, CRISPR gene activation, and pretreatment to improve conversion efficiency in mouse cells, but whether the approach works in human cells and whether the resulting cells have sufficient function remain to be verified.

By SURL BioNews

To study neurological diseases in the laboratory, scientists need nerve cells that reproduce disease characteristics; converting readily accessible skin cells into neurons is one approach. Yet even when conversion instructions enter a cell, they may not reach the genes that control its identity. A UCLA team has now used brief squeezing to loosen this barrier, improving conversion efficiency in mouse cells.

According to a study announced by UCLA on October 22 and published in *Matter*, the team used CRISPR gene activation tools (CRISPRa) to switch on genes involved in neuron formation. These tools work without cutting DNA, but they are still affected by chromatin: the more tightly DNA and proteins are packed, the harder it is for the tools to reach their targets.

The researchers first delivered CRISPRa and guide RNA into adult mouse skin cells in the form of transient RNA, then passed the cells through a microfluidic chip one day later. The chip’s channels were narrower than the cell nuclei, squeezing and deforming the nuclei within milliseconds and temporarily increasing the accessibility of certain DNA regions.

Where the squeezing had an effect was also crucial. The team mapped which genomic regions became more accessible as a result, then used that information to select target sites for guide RNA. Targeting these regions produced stronger activation of genes such as Ascl1 and Brn2; when combined with squeezing, about 10% of cells converted into neurons, compared with about 3% using CRISPRa alone.

The 40% result came from an additional pretreatment step. The researchers first used the same method to activate Oct4, moving the cells toward a more plastic state without fully turning them into stem cells; they then activated neuron-related genes, raising the conversion rate to about 40%. This improvement therefore resulted from several steps working together and cannot be attributed entirely to squeezing itself.

The method is called mechanically enhanced CRISPR-mediated activation, or MECA. It suggests that, beyond delivering tools into cells, adjusting the environment inside the nucleus can help those tools reach their target sites more easily. If further validated, this strategy could help produce cells for disease models and drug testing.

The findings remain limited to mouse cells. According to UCLA, the team will next test conversion in human cells and whether the resulting cells have sufficient function to support drug testing or transplantation. An increased conversion rate alone does not establish that these cells can perform those tasks; moving from producing more cells to producing reliable, usable cells remains the central question for the next stage.

References

  1. UCLA